Abstract
Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) are the first prolonged conflicts the United States has been involved in since the Vietnam War. Throughout history, medical and surgical advances have often emerged from the high-intensity experiences of treating a high volume of battlefield casualties. One of the hallmarks of the current operations in Iraq and Afghanistan has been the prospective capture of data on all patients presenting to US forward military treatment facilities (MTFs). Much of the data has now been consolidated in the Joint Theater Trauma Registry (JTTR), a large military database created to improve the care and outcomes of soldiers.1 This registry has been validated as an important tool in the assessment of casualty care2-4 and has been used to analyze a wide range of trauma topics, including care for extremity wounds,5 airborne critical care,6,7 administration of recombinant factor VII,8 and treatment of infectious diseases.9,10